EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

UPLC-FT-ICR-MS and mechanistic study reveals the protective effect of Callistephus chinensis flower against alcoholic liver disease

Nan YANG, Xuehan LI, Xiaojun WANG, Kexin HUANG, Weizhuo TANG, Xiaoshu ZHANG

Chinese Journal of Analytical Chemistry · 2026-06 · 54 (6) · 100726

DOI: 10.1016/j.cjac.2026.100726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Journal of Analytical Chemistry, 2026-06. Verfasst von Nan YANG und 5 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology of Liaoning Province, Shenyang Pharmaceutical University, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• UPLC-FT-ICR-MS analysis identified 23 major compounds in CCF, primarily flavonoids and phenolic acids. • CCF can effectively reduce inflammatory reaction and inhibit lipid accumulation in liver. • CCF mainly prevents alcoholic liver injury by regulating AMPK and TLR4/NF-κB signaling pathway. • CCF may be a candidate drug for prevention and treatment of ALD. Liver disease caused by excessive alcohol consumption is a serious threat to human health. Previous studies have shown that Callistephus chinensis flower (CCF) can ameliorate alcoholic liver disease (ALD), but its mechanism remains unreported. The chemical composition of CCF was identified in vitro by employing ultra-performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry (UPLC-FT-ICR-MS). C57BL/6J mice were divided into control, ethanol, CCF extract (100, 200, 400 mg/kg), and silymarin (100 mg/kg) groups. Hepatic pathology and lipid infiltration were assessed via H&E and Oil Red O staining. Commercial kits were used to measure TC, TG, AST, ALT, MDA, and GSH-Px levels. IHC was performed for PPARα, IL-1β, F4/80, and TLR4, while Western blot quantified AMPKα, p-AMPKα, PPARα, CPT1α, ACC, and p-ACC. LC-MS/MS preliminarily identified 23 major compounds, with flavonoids and phenolic acids being the predominant components in CCF extract. CCF administration upregulated p-AMPKα, PPARα, and CPT1α, and downregulated TLR4, p-NF-κB, and p-IκBα. It effectively reduced serum inflammatory factors, decreased lipid accumulation, promoted lipid metabolism, and alleviated liver injury by modulating AMPK and TLR4/NF-κB pathways. This study is the first to demonstrate that CCF ameliorates ALD via AMPK and TLR4/NF-κB pathways, providing a potential candidate for ALD treatment.

Förderung

  • Department of Science and Technology of Liaoning Province
  • Shenyang Pharmaceutical University
  • National Natural Science Foundation of China

Zitieren

APA

YANG, N., LI, X., WANG, X., HUANG, K., TANG, W., & ZHANG, X. (2026). UPLC-FT-ICR-MS and mechanistic study reveals the protective effect of Callistephus chinensis flower against alcoholic liver disease. Chinese Journal of Analytical Chemistry, 54(6), 100726. https://doi.org/10.1016/j.cjac.2026.100726

Vancouver

YANG N, LI X, WANG X, HUANG K, TANG W, ZHANG X. UPLC-FT-ICR-MS and mechanistic study reveals the protective effect of Callistephus chinensis flower against alcoholic liver disease. Chinese Journal of Analytical Chemistry. 2026;54(6):100726. doi:10.1016/j.cjac.2026.100726

BibTeX
@article{YANG2026,
  author = {YANG, Nan and LI, Xuehan and WANG, Xiaojun and HUANG, Kexin and TANG, Weizhuo and ZHANG, Xiaoshu},
  title = {UPLC-FT-ICR-MS and mechanistic study reveals the protective effect of Callistephus chinensis flower against alcoholic liver disease},
  journal = {Chinese Journal of Analytical Chemistry},
  year = {2026},
  volume = {54},
  number = {6},
  pages = {100726},
  doi = {10.1016/j.cjac.2026.100726}
}
Kostenlos starten →